Skip to content
Fosun Pharma
-
Fosun Pharma launches US$128M H-Share buyback following gland pharma stake sale
The share repurchase programme will be funded primarily through proceeds from the sale of an approximately 6% stake in Gland Pharma for about US$294 million.